The neuroendocrine protein 7B2 is required for peptide hormone processing in vivo and provides a novel mechanism for pituitary Cushing's disease

Cell

Volumn 96, Issue 5, 1999, Pages 689-700

  Westphal, Christoph H ^a   Muller, Laurent ^b   Zhou, An ^c   Zhu, Xiaorong ^c   Bonner Weir, Susan ^d   Schambelan, Morris ^e   Steiner, Donald F ^c   Lindberg, Iris ^b,d   Leder, Philip ^a,d  

^a HARVARD MEDICAL SCHOOL   (United States)

^b LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

^d JOSLIN DIABETES CENTER   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; CORTICOTROPIN; FURIN; PROTEIN 7B2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; CORTICOTROPIN RELEASE; CUSHING DISEASE; HISTOPATHOLOGY; HORMONE DETERMINATION; HYPOGLYCEMIA; HYPOPHYSIS INTERMEDIATE LOBE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEGRADATION; REGULATORY MECHANISM;

ANIMALIA;

EID: 0033525771     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(00)80579-6     Document Type: Article

References (55)

1. Autelitano, D.J., Lundblad, J.R., Blum, M., and Roberts, J.L. (1989). Hormonal regulation of POMC gene expression. Annu. Rev. Physiol. 51, 715-726.
2. Benjannet, S., Rondeau, N., Day, R., Chretien, M., and Seidah, N.G. (1991). PC1 and PC2 are proprotein convertases capable of cleaving proopiomelanocortin at distinct pairs of basic residues. Proc. Natl. Acad. Sci. USA 88, 3564-3568.
3. Benjannet, S., Savaria, D., Chretien, M., and Seidah, N.G. (1995a). 7B2 is a specific intracellular binding protein of the prohormone convertase PC2. J. Neurochem. 64, 2303-2311.
4. Benjannet, S., Lusson, J., Hamelin, J., Savaria, D., Chretien, M., and Seidah, N.G. (1995b). Structure-function studies on the biosynthesis and bioactivity of the precursor convertase PC2 and the formation of the PC2/7B2 complex. FEBS Lett. 362, 151-155.
5. Benjannet, S., Mamarbachi, A., Hamelin, J., Savaria, D., Munzer, J., Chretien, M., and Seidah, N. (1998). Residues unique to the prohormone convertase PC2 modulate its autoactivation, binding to 7B2 and enzymatic activity. FEBS Lett. 428, 37-42.
6. Bloomquist, B.T., Eipper, B.A., and Mains, R.E. (1991). Prohormone converting enzymes: regulation and evaluation of the function using antisense RNA. Mol. Endocrinol. 5, 2014-2024.
7. Borrelli, E., Sawchenko, P.E., and Evans, R.E. (1992). Pituitary hyperplasia induced by ectopic expression of nerve growth factor. Proc. Natl. Acad. Sci. USA 89, 2764-2768.
8. Bosse, R., Fumagalli, F., Jaber, M., Giros, B., Gainetdinov, R.R., Wetsel, W.C., Missale, C., and Caron, M.G. (1997). Anterior pituitary hyperplasia and dwarfism in mice lacking the dopamine transporter. Neuron 19, 127-138.
9. Braks, J.A.M., and Martens, G.J.M. (1994). 7B2 is a neuroendocrine chaperone that transiently interacts with prohormone convertase PC2 in the secretory pathway. Cell 78, 263-273.
10. Braks, J.A.M., Broers, C.A.M., Danger, J.H.A., and Martens, G.J.M. (1996). Structural organization of the gene encoding the neuroendocrine chaperone 7B2. Eur. J. Biochem. 236, 60-67.
11. Castro, M.G., Gusovsky, F., and Loh, Y.P. (1989). Transmembrane signals mediating adrenocorticotropin release from mouse anterior pituitary cells. Mol. Cell. Endocrinol. 65, 165-173.
12. Chronwall, B.M., Millington, W.R., Griffen, W.S., Unnerstall, J.R., and O'Donohue, T.L. (1987). Histological evaluation of the dopaminergic regulation of proopiomelanocortin gene expression in the intermediate lobe of the rat pituitary, involving in situ hybridization and [3H]thymidine uptake. Endocrinology 120, 1201-1211.
13. Collini, P., Sampietro, G., Luksch, R., Migliorini, L., Boracchi, P., and Scopsi, P. (1998). Differentiation in pediatric peripheral primitive neuroectodermal tumors of bone. Virchows Arch. 432, 505-513.
14. Day, R., Schafer, M.K.H., Watson, S.J., Chretien, M., and Seidah, N.G. (1992). Distribution and regulation of the prohormone convertases PC1 and PC2 in the rat pituitary. Mol. Endocrinol. 6, 485-497.
15. Devine, S.E., and Boeke, J.D. (1994). Efficient integration of artificial transposons into plasmid targets in vitro: a useful tool for DNA mapping, sequencing and genetic analysis. Nucleic Acid Res. 22, 3765-3772.
16. Furuta, M., Yano, H., Zhou, A., Rouille, Y., Holst, J.J., Carroll, R., Ravazzola, M., Orci, L., Furuta, H., and Steiner, D.F. (1997). Defective prohormone processing and altered pancreatic islet morphology in mice lacking active SPC2. Proc. Natl. Acad. Sci. USA 94, 6646-6651.
17. Furuta, M., Carroll, R., Martin, S., Swift, H.H., Ravazzola, M., Orci, L., and Steiner, D.F. (1998). Incomplete processing of proinsulin to insulin accompanied by elevation of Des-31,32 proinsulin intermediates in islets of mice lacking active PC2. J. Biol. Chem. 273, 1-7.
18. Hsi, K.L., Seidah, N.G., De Serres, G., and Chretien, M. (1982). Isolation and NH2-terminal sequence of a novel porcine anterior pituitary polypeptide. Homology to proinsulin, secretin and Rous sarcoma virus transforming protein TVFV60. FEBS Lett. 147, 261-266.
19. Hu, N., Gutsmann, A., Herbert, D.C., Bradley, A., and Lee, W.H. (1994). Heterozygous Rb-1 delta/+ mice are predisposed to tumors of the pituitary grand with a nearly complete penetrance. Oncogene 9, 1021-1027.
20. Iguchi, H., Chan, J.S.D., Seidah, N.G., and Chretien, M. (1984). Tissue distribution and molecular forms of a novel pituitary protein in the rat. Neuroendocrinology 39, 453-458.
21. Jackson, R.S., Creemers, J.W., Ohagi, S., Raffin-Sanson, M.L., Sanders, L., Montague, C.T., Hutton, J.C., and O'Rahilly, S. (1997). Obesity and impaired prohormone processing associated with mutations in the human prohormone convertase 1 gene. Nat. Genet. 16, 303-306.
22. Johanning, K., Mathis, J.P., and Lindberg, I. (1996). Processing site blockade results in more efficient conversion of proenkephalin to active opioid peptides. J. Biol. Chem. 271, 27871-27878.
23. Johanning, K., Juliano, M.A., Juliano, L., Lazure, C., Lamango, N., Steiner, D.F., and Lindberg, I. (1998). Specificity of prohormone convertase 2 on proenkephalin and proenkephalin-related fluorogenic peptides. J. Biol. Chem. 273, 22672-22680.
24. Kelly, M.A., Rubinstein, M., Asa, S.L., Zhang, G., Saez, C., Bunzow, J.R., Allen, R.G., Hnasko, R., Ben-Jonathan, N., Grandy, D.K., and Low, M.J. (1997). Pituitary lactotroph hyperplasia and chronic hyperprolactinemia in dopamine D2 receptor-deficient mice. Neuron 19, 103-113.
25. Lamberts, S.W.J., Klijn, J.G.M., Quijada, M., Timmermans, H.A.T., Utterlinden, P., de Jong, F.H., and Birkenhager, J.C. (1980). The mechanism of the suppressive action of bromocryptine on adrenocorticotropin secretion in patients with Cushing's disease and Nelson's syndrome. J. Clin. Endocrinol. Metab. 51, 307-311.
26. Lindberg, I., Van den Hurk, W.H., Bui, C., and Batie, C.J. (1995). Enzymatic characterization of immunopurified prohormone convertase 2. Potent inhibition by a 7B2 peptide fragment. Biochemistry 34, 5486-5493.
27. Marcinkiewicz, M., Touraine, P., and Chretien, M. (1994). Pan-neuronal mRNA expression of the secretory polypeptide 7B2. Neurosci. Lett. 177, 91-94.
28. McAndrew, J., Paterson, A.J., Asa, S.L, McCarthy, K.J., and Kudlow, J.E. (1995). Targeting of transforming growth factor alpha expression to pituitary lactotrophs in transgenic mice results in selective lactotroph proliferation and adenomas. Endocrinology 136, 4479-4488.
29. Meier, C.A., and Biller, B.M. (1997). Clinical and biochemical evaluation of Cushing's syndrome. Endocrinol. Metab. Clin. North Am. 26, 741-762.
30. Meiner, V.L., Cases, S., Myers, H.M., Sande, E.R., Bellosta, S., Schambelan, M., Pitas, R.E., McGuire, J., Herz, J., and Farese, R.V., Jr. (1996). Disruption of the acyl-CoA:cholesterol acyltransferase gene in mice: evidence suggesting multiple cholesterol esterification enzymes in mammals. Proc. Natl. Acad. Sci. USA 93, 14041-14046.
31. Muller, L., Zhu, X., and Lindberg, I. (1997). Mechanism of the facilitation of PC2 maturation by 7B2: involvement in ProPC2 transport and activation but not folding. J. Cell Biol. 139, 625-638.
32. Ohashi, M., Natori, S., Fujio, N., Iguchi, H., and Nawata, H. (1990). Secretory protein 7B2. A novel tumor marker of medullary carcinoma of the thyroid. Horm. Metab. Res. 22, 114-116.
33. Orth, D.N., and Nicholson, W.E. (1982). Bioactive and immunoreactive adrenocorticotropin in normal equine pituitary and in pituitary tumors of horses with Cushing's disease. Endocrinology 111, 559-563.
34. Oyarce, A.M., Hand, T.A., Mains, R.E., and Eipper, B.A. (1996). Dopaminergic regulation of secretory granule-associated proteins in rat intermediate pituitary. J. Neurochem. 67, 229-241.
35. Roebroek, A.J., Martens, G.J., Duits, A.J., Schalken, J.A., van Bokhoven, A., Wagenaar, S.S., and Van de Ven, W.J. (1989). Differential expression of the gene encoding the novel pituitary polypeptide 7B2 in human lung cancer cells. Cancer Res. 49, 4154-4155.
36. Rosenfeld, M., Bach, I., Erkman, L., Li, P., Lin, S., McEvilly, R., Ryan, A., Rhodes, S., Schonnemann, M., and Scully, K. (1996). Transcriptional control of cell phenotypes in the neuroendocrine system. Recent Prog. Horm. Res. 51, 217-238.
37. Rouille, Y., Westermark, G., Martin, S.K., and Steiner, D.F. (1994). Proglucagon is processed to glucagon by prohormone convertase PC2 in alpha TC1-6 cells. Proc. Natl. Acad. Sci. USA 91, 3242-3246.
38. Rouille, Y., Duguay, S.J., Lund, K., Furuta, M., Gong, Q., Lipkind, G., Oliva, A.A., Jr., Chan, S.J., and Steiner, D.F. (1995). Proteolytic processing mechanisms in the biosynthesis of neuroendocrine peptides: the subtilisin-like proprotein convertases. Front. Neuroendocrinol. 16, 322-361.
39. Rouille, Y., Bianchi, M., Irminger, J.C., and Halban, P.A. (1997). Role of prohormone convertase PC2 in the processing of proglucagon to glucagon. FEBS Lett. 413, 119-123.
40. Saiardi, A., and Borrelli, E. (1998). Absence of dopaminergic control on melanotrophs leads to Cushing's-like syndrome in mice. Mol. Endocrinol. 12, 1133-1139.
41. Schnabel, E., Mains, R.E., and Farquhar, M.G. (1989). Proteolytic processing of proACTH-endorphin begins in the Golgi complex of pituitary corticotropes and AtT-20 cells. Mol. Endocrinol. 3, 1223-1234.
42. Seidah, N.G., and Chretien, M. (1997). Eukaryotic protein processing: endoproteolysis of precursor proteins. Curr. Opin. Biotechnol. 8, 602-607.
43. Seidel, B., Dong, W., Savaria, D., Zheng, M., Pintar, J.E., and Day, R. (1998). The neuroendocrine protein 7B2 is essential for the activation of precursor convertase 2 in vivo. DNA Cell Biol. 17, 1017-1029.
44. Steiner, D.F. (1998). The proprotein convertases. Curr. Opin. Chem. Biol. 2, 31-39.
45. Stenzel-Poore, M.P., Cameron, V.A., Vaughan, J., Sawchenko, P.E., and Vale, W. (1992). Development of Cushing's syndrome in corticotrophin-releasing factor transgenic mice. Endocrinology 130, 3378-3386.
46. Thomas, L., Leduc, R., Thorne, B.A., Smeekens, S.P., Steiner, D., and Thomas, G. (1991). Kex2-like endoproteases PC2 and PC3 accurately cleave a model prohormone in mammalian cells: evidence for a common core of neuroendocrine processing enzymes. Proc. Natl. Acad. Sci. USA 88, 5297-5301.
47. Van Horssen, A.M., and Martens, G.J. (1998). Mapping of the domain in the neuroendocrine protein 7B2 important for its helper function towards prohormone convertase PC2. Mol. Cell Endocrinol. 137, 7-12.
48. Vieau, D., Linard, C.G., Mbikay, M., Lenne, F., Chretien, M., Luton, J.P., and Bertagna, X. (1992). Expression of the neuroendocrine cell marker 7B2 in human ACTH secreting tumors. Clin. Endocrinol. 36, 597-603.
49. Wang, C.C., Chan, D.C., and Leder, P. (1997). The mouse formin(Fmn) gene: genomic structure, novel exons, and genetic mapping. Genomics 39, 303-311.
50. Westphal, C.W., and Leder, P. (1997). Transposon-generated "knock-out" and "knock-in" gene-targeting constructs for use in mice. Curr. Biol. 7, 530-533.
51. Withers, D.J., Gutierrez, J.S., Towery, H., Burks, D.J., Ren, J.M., Previs, S., Zhang, Y., Bernal, D., Pons, S., Shulman, G.I., Bonner-Weir, S., and White, M.F. (1998). Disruption of IRS-2 causes type 2 diabetes in mice. Nature 391, 900-904.
52. Zhou, A., Bloomquist, B.T., and Mains, R.E. (1993). The prohormone convertases PC1 and PC2 mediate distinct endoproteolytic cleavages in a strict temporal order during proopiomelanocortin biosynthetic processing. J. Biol. Chem. 268, 1763-1769.
53. Zhu, X., and Lindberg, I. (1995). 7B2 facilitates the maturation of proPC2 in neuroendocrine cells and is required for the expression of enzymatic activity. J. Cell Biol. 129, 1641-1650.
54. Zhu, X., Lamango, N.S., and Lindberg, I. (1996). Involvement of a polyproline helix-like structure in the interaction of 7B2 with prohormone convertase 2. J. Biol. Chem. 271, 23582-23587.
55. Zhu, X., Muller, L., Mains, R.E., and Lindberg, I. (1998). Structural elements of PC2 required for interaction with its helper protein 7B2. J. Biol. Chem. 273, 1158-1164.